These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36535726)

  • 1. Effect of discharge opioid on persistent postoperative opioid use: a retrospective cohort study comparing tapentadol with oxycodone.
    Lam T; Xia T; Biggs N; Treloar M; Cheng O; Kabu K; Stevens JA; Evans JD; da Gama ME; Lubman DI; Nielsen S
    Anaesthesia; 2023 Apr; 78(4):420-431. PubMed ID: 36535726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing opioid types in the persistence of opioid use following surgical admission: a study protocol for a retrospective observational linkage study comparing tapentadol and oxycodone in Australia.
    Lam T; Biggs N; Xia T; Evans J; Stevens J; da Gama M; Lubman DI; Nielsen S
    BMJ Open; 2022 Apr; 12(4):e060151. PubMed ID: 35418442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of opioid prescribing upon hospital discharge in patients receiving tapentadol versus oxycodone following orthopaedic surgery.
    Wang X; Tay HP; Narayan SW; Penm J; Patanwala AE
    Int J Clin Pharm; 2021 Dec; 43(6):1602-1608. PubMed ID: 34089144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the risks of opioid abuse or dependence between tapentadol and oxycodone: results from a cohort study.
    Cepeda MS; Fife D; Ma Q; Ryan PB
    J Pain; 2013 Oct; 14(10):1227-41. PubMed ID: 23850177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of opioid doctor shopping for tapentadol and oxycodone: a cohort study.
    Cepeda MS; Fife D; Vo L; Mastrogiovanni G; Yuan Y
    J Pain; 2013 Feb; 14(2):158-64. PubMed ID: 23253635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the risks of shopping behavior and opioid abuse between tapentadol and oxycodone and association of shopping behavior and opioid abuse.
    Cepeda MS; Fife D; Kihm MA; Mastrogiovanni G; Yuan Y
    Clin J Pain; 2014 Dec; 30(12):1051-6. PubMed ID: 24370606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence with opioids post discharge from hospitalisation for surgery in Australian adults: a retrospective cohort study.
    Roughead EE; Lim R; Ramsay E; Moffat AK; Pratt NL
    BMJ Open; 2019 Apr; 9(4):e023990. PubMed ID: 30992289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing trend of tapentadol in a Sydney local health district.
    Mirabella J; Ravi D; Chiew AL; Buckley NA; Chan BS
    Br J Clin Pharmacol; 2022 Sep; 88(9):3929-3935. PubMed ID: 35763675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
    Hartrick C; Van Hove I; Stegmann JU; Oh C; Upmalis D
    Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal Adverse Events in Hospitalized Patients Following Orthopedic Surgery: Tapentadol Immediate Release Versus Oxycodone Immediate Release.
    Wang X; Narayan SW; Penm J; Johnstone C; Patanwala AE
    Pain Physician; 2021 May; 24(3):E309-E315. PubMed ID: 33988952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine.
    Ikenberg R; Hertel N; Moore RA; Obradovic M; Baxter G; Conway P; Liedgens H
    J Med Econ; 2012; 15(4):724-36. PubMed ID: 22364286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post hoc analyses of data from a 90-day clinical trial evaluating the tolerability and efficacy of tapentadol immediate release and oxycodone immediate release for the relief of moderate to severe pain in elderly and nonelderly patients.
    Vorsanger G; Xiang J; Biondi D; Upmalis D; Delfgaauw J; Allard R; Moskovitz B
    Pain Res Manag; 2011; 16(4):245-51. PubMed ID: 22059194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Delirium With Different Oral Opioids in Previously Opioid-Naive Patients.
    Sugiyama Y; Tanaka R; Sato T; Sato T; Saitoh A; Yamada D; Shino M
    Am J Hosp Palliat Care; 2022 Oct; 39(10):1145-1151. PubMed ID: 35045754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between presurgical opioid type and persistent postoperative opioid use: a retrospective observational linkage study comparing tapentadol and oxycodone.
    Michell E; Lam T; Xia T; Nielsen S; Stevens J
    Anaesthesia; 2024 Feb; 79(2):203-205. PubMed ID: 37932877
    [No Abstract]   [Full Text] [Related]  

  • 15. Does prescribing of immediate release oxycodone by emergency medicine physicians result in persistence of Schedule 8 opioids following discharge?
    Veal F; Thompson A; Halliday S; Boyles P; Orlikowski C; Huckerby E; Bereznicki L
    Emerg Med Australas; 2020 Jun; 32(3):489-493. PubMed ID: 31837655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tapentadol immediate release versus oxycodone immediate release for treatment of acute low back pain.
    Biondi D; Xiang J; Benson C; Etropolski M; Moskovitz B; Rauschkolb C
    Pain Physician; 2013; 16(3):E237-46. PubMed ID: 23703422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone.
    Haeseler G; Schaefers D; Prison N; Ahrens J; Liu X; Karch A
    BMC Anesthesiol; 2017 Jul; 17(1):91. PubMed ID: 28693439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of study discontinuations with tapentadol inmmediate release and oxycodone immediate release in patients with low back or osteoarthritis pain.
    Vorsanger G; Xiang J; Okamoto A; Upmalis D; Moskovitz B
    J Opioid Manag; 2010; 6(3):169-79. PubMed ID: 20642246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sustained-release Opioids: Morphine, Oxycodone and Tapentadol].
    Takahashi Y; Iseki M
    Masui; 2015 Nov; 64(11):1133-40. PubMed ID: 26689063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tapentadol Versus Oxycodone for Opioid-Related Adverse Drug Events and Clinical Outcomes After Inpatient Surgery.
    Liu S; Patanwala AE; Naylor JM; Stevens JA; Bugeja B; Begley D; Khor KE; Lau E; Adie S; Penm J
    J Pain; 2024 Feb; 25(2):466-475. PubMed ID: 37741523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.